Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

Eaton 02_28_18 Transatlantic Tax Group

Transatlantic Tax Group Finance Bill Seminar 2018

Transatlantic Tax Group Finance Bill Seminar 2018

Summary

Related Content

UK Government announces update on new carried interest tax regime

UK Salaried Member Employment Tax Rules - Recent Developments

Pillar II in Luxembourg: What Investment Funds Need to Know

A new UK-based unauthorised fund vehicle now available - The Reserved Investor Fund

2025 Budget Resolution Update: Tax Implications

Tax Update in Luxembourg Regarding Interest Rates for Shareholder Current Accounts

Loi de Finances pour 2025

Fiscalité des « management packages »

The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers

Chambers USA 2025 Recognizes a Record Number of Goodwin Practices and Lawyers for Exceptional Client Service

Goodwin Advises Edmond de Rothschild REIM on Acquisition Financing for "The Q Frankfurt" Development

Vigil Neuroscience To Be Acquired by Sanofi For $470 Million and Contingent Value Rights

Kronos Bio To Be Taken Private by Concentra Biosciences

SpringWorks Therapeutics To Be Acquired By Merck KGaA, Darmstadt, Germany For $3.9 Billion

Goodwin Advises Paragon on Acquisition Financing for Dymatrix

Goodwin Advises Gimv on the Financing of the Acquisition of Unizell and the Refinancing of Medi-Markt Group, Now Known as Liveo Group

Tax